- Update on Company's clinical and preclinical programs - 4 clinical study read-outs anticipated over the next 12 to 18 months - Targeting pathologies characterized by membrane dysfunction with substantial commercial opportunity
SAN DIEGO , Aug.
- Q2 Revenue of $1.1 Billion - Q2 Continuing Operations Adjusted EBITDA of $106 Million - Q2 Continuing Operations Adjusted Diluted EPS of $0.40
- Issues Guidance for the remainder of 2014 CORAL GABLES, Fla.
Mavenir Systems ® (NYSE:MVNR), a leading provider of
software-based networking solutions, announced today that it is among
the top five most installed IMS infrastructure vendors recognized by
operators in Infonetics Research’s IMS
Services Strategies and Vendor Leadership: Global Service Provider Survey .
MDC Partner Network Augments Support of Partner Agencies with Addition of Lori Senecal Senecal Takes on Role of President & CEO of MDC Partner Network, Adding Agency Leadership Experience to Depth of MDC Partners Strategic Resources Andre Coste to Take on Role of MDC Partner Network Chief Operating Officer Canada NewsWire
NEW YORK , Aug.
Senecal Takes on Role of President & CEO of MDC Partner Network, Adding Agency Leadership Experience to Depth of MDC Partners Strategic Resources Andre Coste to Take on Role of MDC Partner Network Chief Operating Officer
NEW YORK , Aug.
Mentor Graphics Corporation (NASDAQ:MENT) today announced they will
release financial results for the company's second fiscal quarter, ended
July 31, 2014, on Thursday, August 21, 2014, at approximately 1:15 p.m.
Sign-up for Merrimack Pharmaceuticals Announces Initiation of HERMIONE, a Randomized Trial of MM-302 in Patients With Advanced HER2-Positive Breast Cancer to Support Application for Accelerated Approval investment picks
By Benjamin Pimentel, MarketWatch
Microsoft unveils the entry-level Nokia 130
-Benjamin Pimentel; 415-439-6400; AskNewswires@dowjones.com
SAN FRANCISCO (MarketWatch) -- Microsoft is rolling out a $25 phone for consumers in Asia and Africa in a clear bid to expand its presence in emerging markets.
Molina Healthcare, Inc. (NYSE:MOH) (the “Company”) announced today that
it has entered into separate, privately-negotiated, exchange agreements
with five holders of the Company’s outstanding 3.75% Convertible Senior
Notes due 2014 (“Existing Notes”). Pursuant to the terms of these
exchange agreements, the Company will exchange $68.872 million aggregate
principal amount of Existing Notes (which represents approximately 37%
of the outstanding Existing Notes) for $68.872 million aggregate
principal amount of new 1.625% Convertible Senior Notes due 2044 (“2044
Notes”), a certain number of shares of the Company’s common stock (with
such number rounded down to the nearest whole share for each holder and
determined based on the arithmetic average of the daily volume weighted
average prices of the Company’s common stock as published on Bloomberg
page “MOH <equity> AQR” over a 10 trading day period
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.